Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022728
Filing Date
2019-11-14
Accepted
2019-11-13 19:18:46
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q innv20190930_10q.htm 10-Q 982114
2 EXHIBIT 31.1 ex_155565.htm EX-31.1 13463
3 EXHIBIT 31.2 ex_155566.htm EX-31.2 13631
4 EXHIBIT 32.1 ex_155567.htm EX-32.1 5196
  Complete submission text file 0001437749-19-022728.txt   5656959

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT innv-20190930.xml EX-101.INS 1098341
6 XBRL TAXONOMY EXTENSION SCHEMA innv-20190930.xsd EX-101.SCH 66306
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20190930_cal.xml EX-101.CAL 44840
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20190930_def.xml EX-101.DEF 424892
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20190930_lab.xml EX-101.LAB 397114
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20190930_pre.xml EX-101.PRE 448608
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 191215803
SIC: 2834 Pharmaceutical Preparations